Merck Discontinues Two Oncology Candidates Following Unsatisfactory Late-Stage Outcomes

Merck Discontinues Two Oncology Candidates Following Unsatisfactory Late-Stage Outcomes

Merck Discontinues Two Oncology Candidates Following Unsatisfactory Late-Stage Outcomes